Article Information
- Received July 25, 2011
- Revision received August 22, 2011
- Accepted August 24, 2011
- First published October 19, 2011.
- Version of record published October 19, 2011.
Author Information
- Nashat Abumaria1,
- Bin Yin1,
- Ling Zhang1,
- Xiang-Yao Li2,
- Tao Chen2,
- Giannina Descalzi2,
- Liangfang Zhao1,
- Matae Ahn1,
- Lin Luo1,
- Chen Ran1,
- Min Zhuo2, and
- Guosong Liu1,3
- 1Tsinghua-Peking Center for Life Sciences, School of Medicine, Tsinghua University, 100084 Beijing, China,
- 2Department of Physiology, Faculty of Medicine, University of Toronto, Toronto, Ontario M5S 1A8, Canada, and
- 3Center for Learning and Memory, School of Medicine, University of Texas at Austin, Austin, Texas 78712
Author contributions
Author contributions: N.A., M.Z., and G.L. designed research; N.A., B.Y., L. Zhang, X.Y.L., T.C., G.D., L. Zhao, M.A., L.L., and C.R. performed research; N.A., B.Y., L. Zhang, and X.Y.L. analyzed data; N.A. and G.L. wrote the paper.
Disclosures
- Received July 25, 2011.
- Revision received August 22, 2011.
- Accepted August 24, 2011.
This work was supported by grants from Tsinghua-Yue-Yuen Medical Sciences Fund (to N.A.), China Scientific Foundation (Grant for Post Doc 023205002, to N.A.), the National Natural Science Foundation of China (Grant for Youth Scientists 30901796/H3101, to N.A; and 30630026, to G.L.), National Basic Research Program of China (Grant 2006CB3031, to G.L.), and The National High Technology Research and Development Program of China (2007AA02Z443, to G.L.). M.Z. was supported by grants from the EJLB-CIHR Michael Smith Chair in Neurosciences and Mental Health, Canada Research Chair, and CIHR operating grants (CIHR66975 and CIHR84256). X.Y.L. and T.C. were supported by postdoctoral fellowships from Fragile X Research Foundation of Canada. We thank Jack Feldman and David Glanzman for comments on the manuscript.
Guosong Liu declares that he is a cofounder of Magceutics, a company whose goal is to develop drugs to treat age-dependent memory decline and Alzheimer's disease. He also reports his United States patent application on Magnesium-l-Threonate. All other authors report no financial interests or potential conflicts of interest related to the current study.
- Correspondence should be addressed to Guosong Liu, Center for Learning and Memory, School of Medicine, Tsinghua University, 100084 Beijing, China. liu.guosong{at}gmail.com